Effects of live and heat-killed Bifidobacterium lactis in rats with induced periodontitis
DOI:
https://doi.org/10.1590/1678-7765-2025-0634Keywords:
Periodontitis, Probiotics, Bifidobacterium animalis subsp lactis, PostbioticsAbstract
Background Probiotics and postbiotics have emerged as promising adjunctive therapies in managing periodontal disease. Bifidobacterium animalis subsp. lactis HN019 has shown antimicrobial and immunomodulatory effects in both experimental and clinical settings when administered orally. However, the systemic impact of this strain, independent of local oral effects, remains unclear.
Objective To evaluate the systemic effects of live and heat-killed B. animalis subsp. lactis HN019 in a rat model of ligature-induced periodontitis, excluding direct contact with the oral cavity. Methodology A total of 32 Wistar rats were randomly assigned to four groups (n=8): control (C), periodontitis only (EP), periodontitis + probiotic (PRO), and periodontitis + postbiotic (POS). Periodontitis was induced by placing a cotton ligature around the cervical region of the lower right first molar, inserted into the gingival sulcus. Treatments were administered via oral gavage for 30 days before and 15 days after periodontitis induction. Alveolar bone loss and periodontal parameters were assessed using micro-computed tomography (microCT) and histomorphometric analysis. Results MicroCT revealed that ligature effectively induced periodontitis, reducing BV/TV and Tb.N and increasing Tb.Sp and Po.Tot. Probiotic and postbiotic treatments did not improve outcomes. Bone loss was lowest in the control group, with no differences between EP, PRO, and POS. Conclusion Systemic administration of Bifidobacterium animalis subsp. lactis HN019 or its derived postbiotic resulted in no significant improvements in periodontal outcomes in this experimental model. Further investigations using integrative approaches are needed to better characterize the systemic effects of probiotics and postbiotics.
Downloads
References
1- Dye BA. Global periodontal disease epidemiology. Periodontol 2000. 2012;58(1):10-25. doi: 10.1111/j.1600-0757.2011.00413.x
» https://doi.org/10.1111/j.1600-0757.2011.00413.x
2- Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89 Suppl 1:S173-82. doi: 10.1002/jper.17-0721
» https://doi.org/10.1002/jper.17-0721
3- Beck JD, Papapanou PN, Philips KH, Offenbacher S. Periodontal medicine: 100 years of progress. J Dent Res. 2019;98(10):1053-62. doi: 10.1177/0022034519846113
» https://doi.org/10.1177/0022034519846113
4- Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Beglundh T, et al. Treatment of stage I-III periodontitis: the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47 Suppl 22:4-60. doi: 10.1111/jcpe.13290
» https://doi.org/10.1111/jcpe.13290
5- Balta MG, Papathanasiou E, Blix IJ, Van Dyke TE. Host modulation and treatment of periodontal disease. J Dent Res. 2021;100(8):798-809. doi: 10.1177/0022034521995157
» https://doi.org/10.1177/0022034521995157
6- Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000. 2020;84(1):14-34. doi: 10.1111/prd.12331
» https://doi.org/10.1111/prd.12331
7- Alsakr A. Periodontal diseases and host modulation therapies. J Pharm Bioallied Sci. 2025;17(Suppl 3):S2052-S2054. doi: 10.4103/jpbs.jpbs_537_25
» https://doi.org/10.4103/jpbs.jpbs_537_25
8- World Health Organization. Food and Agriculture Organization of the United Nations. Probiotics in food: health and nutritional properties and guidelines for evaluation [internet]. Rome: WHO; 2006 [cited January 22;2026]. Available from: http://www.fao.org/3/a-a0512e.pdf
» http://www.fao.org/3/a-a0512e.pdf
9- Homayouni Rad A, Pourafar H, Mirzakhani E. A comprehensive review of the application of probiotics and postbiotics in oral health. Front Cell Infect Microbiol. 2023;13:1120995. doi: 10.3389/fcimb.2023.1120995
» https://doi.org/10.3389/fcimb.2023.1120995
10- Matsubara VH, Fakhruddin KS, Ngo H, Samaranayake LP. Probiotic Bifidobacteria in managing periodontal disease: a systematic review. Int Dent J. 2023;73(1):11-20. doi: 10.1016/j.identj.2022.11.018
» https://doi.org/10.1016/j.identj.2022.11.018
11- Ochôa C, Castro F, Bulhosa JF, Manso C, Fernandes JC, Fernandes GV. Influence of the probiotic L. reuteri on periodontal clinical parameters after nonsurgical treatment: a systematic review. Microorganisms. 2023;11(6):1449. doi: 10.3390/microorganisms11061449
» https://doi.org/10.3390/microorganisms11061449
12- Mendonça CD, Mata AD, Azevedo LF, Marques JF, Silveira JM, Marques DN. Probiotics in the non-surgical treatment of periodontitis: a systematic review and network meta-analysis. BMC Oral Health. 2024;24(1):1224. doi: 10.1186/s12903-024-05027-6
» https://doi.org/10.1186/s12903-024-05027-6
13- Cheng J, Laitila A, Ouwehand AC. Bifidobacterium animalis subsp. lactis HN019 effects on gut health: a review. Front Nutr. 2021;8:790561. doi: 10.3389/fnut.2021.790561
» https://doi.org/10.3389/fnut.2021.790561
14- Messora MR, Oliveira LF, Foureaux RC, Taba M Jr, Zangerônimo MG, Furlaneto FA, et al. Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis. J Periodontol. 2013;84(12):1818-26. doi: 10.1902/jop.2013.120644
» https://doi.org/10.1902/jop.2013.120644
15- Oliveira LF, Salvador SL, Silva PH, Furlaneto FA, Figueiredo L, Casarin R, et al. Benefits of Bifidobacterium animalis subsp. lactis probiotic in experimental periodontitis. J Periodontol. 2017;88(2):197-208. doi: 10.1902/jop.2016.160217
» https://doi.org/10.1902/jop.2016.160217
16- Oliveira LF, Silva PH, Salvador SL, Ervolino E, Casarin R, Figueiredo L, et al. Probiotic consumption can modify the resilience of periodontal tissues in rats under experimental periodontitis. J Periodontol. 2023;94(2):217-29. doi: 10.1002/jper.21-0555
» https://doi.org/10.1002/jper.21-0555
17- Invernici MM, Salvador SL, Silva PH, Soares MS, Casarin R, Palioto DB, et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: a randomized clinical trial. J Clin Periodontol. 2018;45(10):1198-1210. doi: 10.1111/jcpe.12995
» https://doi.org/10.1111/jcpe.12995
18- Invernici MM, Furlaneto FA, Salvador SL, Ouwehand AC, Salminen S, Mantziari A, et al. Bifidobacterium animalis subsp. lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients. PLoS One. 2020;15(9):e0238425. doi: 10.1371/journal.pone.0238425
» https://doi.org/10.1371/journal.pone.0238425
19- Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-67. doi: 10.1038/s41575-021-00440-6
» https://doi.org/10.1038/s41575-021-00440-6
20- Moraes RM, Schlagenhauf U, Anbinder AL. Outside the limits of bacterial viability: postbiotics in the management of periodontitis. Biochem Pharmacol. 2022;201:115072. doi: 10.1016/j.bcp.2022.115072
» https://doi.org/10.1016/j.bcp.2022.115072
21- Bertazzoni E, Donelli G, Midtvedt T, Nicoli J, Sanz Y. Probiotics and clinical effects: is the number what counts? J Chemother. 2013;25(4):193-212. doi: 10.1179/1973947813Y.0000000078
» https://doi.org/10.1179/1973947813Y.0000000078
22- Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi: 10.1371/journal.pbio.3000410
» https://doi.org/10.1371/journal.pbio.3000410
23- Moraes RM, Lescura CM, Milhan NV, Ribeiro JL, Silva FA, Anbinder AL. Live and heat-killed Lactobacillus reuteri reduce alveolar bone loss on induced periodontitis in rats. Arch Oral Biol. 2020;119:104894. doi: 10.1016/j.archoralbio.2020.104894
» https://doi.org/10.1016/j.archoralbio.2020.104894
24- Araujo LD, Silva RA, Silva CM, Salvador SL, Messora MR, Furlaneto FA, et al. Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro. Braz J Microbiol. 2023;54(3):2289-95. doi: 10.1007/s42770-023-01083-2
» https://doi.org/10.1007/s42770-023-01083-2
25- Kumar G, Tewari S, Tagg J, Chikindas ML, Popov IV, Tiwari SK. Can probiotics emerge as effective therapeutic agents in apical periodontitis? A review. Probiotics Antimicrob Proteins. 2021;13(2):299-314. doi: 10.1007/s12602-021-09750-2
» https://doi.org/10.1007/s12602-021-09750-2
26- Ribeiro JL, Santos TA, Garcia MT, Carvalho BF, Esteves JE, Moraes RM, et al. Heat-killed Limosilactobacillus reuteri ATCC PTA 6475 prevents bone loss in ovariectomized mice: a preliminary study. PLoS One. 2024;19(5):e0304358. doi: 10.1371/journal.pone.0304358
» https://doi.org/10.1371/journal.pone.0304358
27- Kayser E, He F, Nixon S, Howard-Varona A, Lamelas A, Martinez-Blanch J, et al. Effects of supplementation of live and heat-treated Bifidobacterium animalis subspecies lactis CECT 8145 on glycemic and insulinemic response, fecal microbiota, systemic biomarkers of inflammation, and white blood cell gene expression of adult dogs. J Anim Sci. 2024;102:skae291. doi: 10.1093/jas/skae291
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.